Target intelligence / Profile preview

Multiple pathways via secreted paracrine factors and exosomes

Molecular classification
Other
01

Overview

Multiple pathways via secreted paracrine factors and exosomes refers to a complex network of intercellular communication mechanisms rather than a single molecular target. Paracrine signaling involves the secretion of chemical messengers, such as growth factors and cytokines, which induce changes in neighboring cells (NIH, 2023). Exosomes are a subset of extracellular vesicles that transport bioactive molecules, including proteins, lipids, and various RNA species, to recipient cells to modulate their function (PubMed, 2021). These pathways play critical roles in physiological processes like tissue repair and immune regulation, but are also implicated in pathological states such as cancer metastasis and inflammatory diseases (Nature Reviews Cancer, 2018). Because this term encompasses a vast array of distinct signaling molecules and receptors, it is considered a biological process or mechanism of action rather than a discrete therapeutic target. Therapeutic strategies often focus on specific components within these pathways, such as inhibiting specific exosome biogenesis or neutralizing individual paracrine ligands. In regenerative medicine, the secretome of stem cells is being explored as a cell-free alternative to traditional cell therapies (PubMed, 2022). Overall, understanding these pathways is essential for developing targeted interventions that can precisely modulate the cellular microenvironment.

Other names
Paracrine signalingExosome-mediated communicationSecretome-mediated signalingExtracellular vesicle signaling
02

Mechanism of action

Not applicable as this represents a collection of biological processes rather than a single drug target.

03

Biological functions

Signal transductionCell-to-cell communicationExtracellular vesicle transportParacrine signaling
04

Disease associations

CancerInflammationCardiovascular diseaseNeurodegenerative disease
05

Safety considerations

Complexity of multi-pathway modulationPotential for systemic off-target effectsDifficulty in isolating specific therapeutic components within the secretome
06

Biomarkers

CD63CD81CD9AlixTSG101

Beyond the preview

Go deeper on Multiple pathways via secreted paracrine factors and exosomes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple pathways via secreted paracrine factors and exosomes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call